First Edition: Friday, Dec. 5, 2025
Today's early morning highlights from the major news organizations.
The independent source for health policy research, polling, and news.
1,841-1,860 of 113,154 results
Today's early morning highlights from the major news organizations.
Opinion writers delve into these public health topics.
No major overhaul seems possible before the end of the year, but optimism remained for an extension. Other news from Capitol Hill is on fraudulent Obamacare signups, President Donald Trump's role in any potential health care deal, health insurance affordability, and more.
CEO Brian Thompson was gunned down Dec. 4, 2024, on a sidewalk outside a Manhattan hotel where UnitedHealth Group was holding its annual investors' meeting. In the year since, the case against shooting suspect Luigi Mangione, 27, has played out in pop culture in a way unlike anything in the modern media age, Baltimore Magazine writes.
Indian drugmaker Dr. Reddy's Laboratories will be allowed to make a generic version of Novo Nordisk's semaglutide and export it even before some of Novo's global patents expire in 2026.
Senate Bill 8 restricts the kind of bathrooms in public spaces that are available to transgender people and holds institutions liable for violations of the law. Meanwhile, the University of Texas San Antonio is forcing students to change dorms to comply with the new law. Also in the news: California, North Carolina, Georgia, Minnesota, Missouri, and Ohio.
The birth-dose recommendation has been in place since 1991. The Advisory Committee for Immunization Practices will meet again Friday to debate broader changes to the timing of vaccines given to children, as well as whether aluminum salts should be removed from vaccines, The New York Times reported. Plus, CIDRAP takes a deeper dive into the success of the newborn hep B shot.
Theresa Michele, the director of the Office of Nonprescription Drugs, has been reassigned. Tracy Beth Høeg will take the reins at the Center for Drug Evaluation and Research. Also, Richard Pazdur's abrupt retirement from CDER has reignited fears that the agency is imploding, Axios reports.
Today's early morning highlights from the major news organizations.
The measure has bipartisan support in the Senate and is expected to pass. Meanwhile, with the clock ticking down on Affordable Care Act subsidies, it doesn't appear Congress will find common ground and extend those tax credits to Americans insured through Obamacare.
Richard Pazdur was named director of the Center for Drug Evaluation and Research, or CDER, in November. He was the fourth person in the position this year and had been expected to help stabilize the agency. More administration news is on SNAP, Veterans Affairs, ICE activity, and more.
The federal judge's new injunction would remove the onus on states to figure out which of their health care providers are covered by the ban and to stop funding the non-abortion services the clinics provide to Medicaid patients, Politico reports. The injunction is paused for seven days to allow the Justice Department to appeal to a higher court.
Consumer groups expressed concern over the pullback. Other health care industry news is on physician burnout, AI scribes, pharmacy benefit managers, and more.
The city's lawsuit names Kraft Heinz, Mondelez, Post, Coca-Cola, PepsiCo, General Mills, Nestle USA, Kellogg, Mars, and ConAgra Brands. Other news is on dementia, cancer, norovirus, and more.
Opinion writers examine these public health topics.
The Advisory Committee on Immunization Practices this week is reconsidering whether hepatitis B shots should be given at birth and whether some combination vaccines should be given separately.
Today's early morning highlights from the major news organizations.
In 2023, New Jersey's attorney general subpoenaed the names of donors to First Choice Women’s Resource Centers as part of an investigation into whether the organization was misrepresenting itself. Today, the Supreme Court will hear arguments in the case.
Opinion writers tackle these public health issues.
© 2026 KFF